Sign inJoin waitlistJoin the waitlist

Reynold Panettieri

Vice Chancellor Of Rutgers Institute for Translational Medicine and Science · Rutgers Health

Credentials: · · · · ·

History

Rutgers Institute for Translational Medicine and Science Center · Rutgers Health
Present
Rutgers Health
Present
University of Pennsylvania Health System
Present

Hospital of the University of Pennsylvania
1986–1989
University of Pennsylvania
1988–1989
Hospital of the University of Pennsylvania
1983–1986
Perelman School of Medicine at the University of Pennsylvania
1979–1983

Research

The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy
Nature · 1991 · 815 citations
Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)
Journal of Biological Chemistry · 2002 · 370 citations
Asthma outcomes: biomarkers
Journal of Allergy and Clinical Immunology · 2012 · 296 citations

Martin Blaser
20 papers
DH
Daniel Horton
19 papers
Aili Lazaar
17 papers · 3 as a fellow
BC
Bradley Chipps
17 papers
Paul Moore
16 papers · 12 as a fellow
NL
Njira Lugogo
14 papers
Jeffrey Carson
13 papers
Charles Emala
11 papers
FT
Frank Trudo
10 papers
KD
Kirk Druey
10 papers
EI
Elliot Israel
9 papers
Sally Wenzel
9 papers

Grants

NJ ACTS: A Platform for Translational Science in New Jersey
National Center for Advancing Translational Sciences · UM1
Contact PI · $16.8M · Rutgers Biomedical and Health Sciences
2024–2031
Exploiting Emerging Ideas in G Protein-Coupled Receptor Biology and Pharmacology to Treat Asthma
National Heart, Lung, and Blood Institute · P01
Project lead · $1.4M · Thomas Jefferson University
2025–2030
Learning Health System Scientist Training And Research in New Jersey (LHS STAR NJ)
Agency for Healthcare Research and Quality · P30
Project lead · $1.6M · Rutgers Biomedical and Health Sciences
2024–2028
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma
National Heart, Lung, and Blood Institute · P01
Contact PI · $23.9M · Rutgers Biomedical and Health Sciences
2013–2025

Clinical trials

Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection
Principal investigator · Terminated · Phase 2
Evelo Biosciences, Inc.
2020–2021
Rutgers COVID-19 Cohort Study
Principal investigator · Completed
Rutgers, The State University of New Jersey
2020–2024
A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation
Principal investigator · Completed · Phase 3
AstraZeneca
2016–2018
A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
Principal investigator · Completed · Phase 3
AstraZeneca
2014–2017